Tag Archives: VENTANA CLDN18 (43-14A) RxDx Assay

Roche Secures CE Certification for Groundbreaking Companion Diagnostic Aiding Gastric Cancer Treatment

(IN BRIEF) Roche has announced the CE certification of its VENTANA CLDN18 (43-14A) RxDx Assay, marking a significant advancement in companion diagnostics for patients with gastric and gastroesophageal junction (GEJ) adenocarcinoma. This diagnostic tool enables clinicians to identify patients who … Read the full press release